Edward Pershing - CEO, Director at Provectus Biopharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, Director
Stock Symbol
PVCT on OTC
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Edward Pershing since 1/8/2024

Holdings reported by Edward Pershing for Provectus Biopharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Options (Right to Buy) 25.5M Dec 2, 2024 Direct Common Stock
Series D-1 Convertible Preferred Stock 1.71M Nov 29, 2024 Direct Common Stock
8% Unsecured Convertible Promissory Note $2.13M Nov 29, 2024 Direct Series D-1 Convertible Preferred Stock

Transactions reported by Edward Pershing for Provectus Biopharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.